Literature DB >> 26595809

Aberrant sodium influx causes cardiomyopathy and atrial fibrillation in mice.

Elaine Wan, Jeffrey Abrams, Richard L Weinberg, Alexander N Katchman, Joseph Bayne, Sergey I Zakharov, Lin Yang, John P Morrow, Hasan Garan, Steven O Marx.   

Abstract

Increased sodium influx via incomplete inactivation of the major cardiac sodium channel Na(V)1.5 is correlated with an increased incidence of atrial fibrillation (AF) in humans. Here, we sought to determine whether increased sodium entry is sufficient to cause the structural and electrophysiological perturbations that are required to initiate and sustain AF. We used mice expressing a human Na(V)1.5 variant with a mutation in the anesthetic-binding site (F1759A-Na(V)1.5) and demonstrated that incomplete Na+ channel inactivation is sufficient to drive structural alterations, including atrial and ventricular enlargement, myofibril disarray, fibrosis and mitochondrial injury, and electrophysiological dysfunctions that together lead to spontaneous and prolonged episodes of AF in these mice. Using this model, we determined that the increase in a persistent sodium current causes heterogeneously prolonged action potential duration and rotors, as well as wave and wavelets in the atria, and thereby mimics mechanistic theories that have been proposed for AF in humans. Acute inhibition of the sodium-calcium exchanger, which targets the downstream effects of enhanced sodium entry, markedly reduced the burden of AF and ventricular arrhythmias in this model, suggesting a potential therapeutic approach for AF. Together, our results indicate that these mice will be important for assessing the cellular mechanisms and potential effectiveness of antiarrhythmic therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26595809      PMCID: PMC4701549          DOI: 10.1172/JCI84669

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart.

Authors:  M L Valencik; J A McDonald
Journal:  Transgenic Res       Date:  2001-06       Impact factor: 2.788

2.  Charge at the lidocaine binding site residue Phe-1759 affects permeation in human cardiac voltage-gated sodium channels.

Authors:  Megan M McNulty; Gabrielle B Edgerton; Ravi D Shah; Dorothy A Hanck; Harry A Fozzard; Gregory M Lipkind
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

3.  Identification of novel interaction sites that determine specificity between fibroblast growth factor homologous factors and voltage-gated sodium channels.

Authors:  Chaojian Wang; Chuan Wang; Ethan G Hoch; Geoffrey S Pitt
Journal:  J Biol Chem       Date:  2011-05-12       Impact factor: 5.157

4.  Hypoxia increases persistent sodium current in rat ventricular myocytes.

Authors:  Y K Ju; D A Saint; P W Gage
Journal:  J Physiol       Date:  1996-12-01       Impact factor: 5.182

5.  Increased late sodium current in myocytes from a canine heart failure model and from failing human heart.

Authors:  Carmen R Valdivia; William W Chu; Jielin Pu; Jason D Foell; Robert A Haworth; Mathew R Wolff; Timothy J Kamp; Jonathan C Makielski
Journal:  J Mol Cell Cardiol       Date:  2005-03       Impact factor: 5.000

6.  Cardiac-specific overexpression of SCN5A gene leads to shorter P wave duration and PR interval in transgenic mice.

Authors:  Teng Zhang; Sandro L Yong; Xiao-Li Tian; Qing K Wang
Journal:  Biochem Biophys Res Commun       Date:  2007-02-07       Impact factor: 3.575

7.  Meta-analysis identifies six new susceptibility loci for atrial fibrillation.

Authors:  Patrick T Ellinor; Kathryn L Lunetta; Christine M Albert; Nicole L Glazer; Marylyn D Ritchie; Albert V Smith; Dan E Arking; Martina Müller-Nurasyid; Bouwe P Krijthe; Steven A Lubitz; Joshua C Bis; Mina K Chung; Marcus Dörr; Kouichi Ozaki; Jason D Roberts; J Gustav Smith; Arne Pfeufer; Moritz F Sinner; Kurt Lohman; Jingzhong Ding; Nicholas L Smith; Jonathan D Smith; Michiel Rienstra; Kenneth M Rice; David R Van Wagoner; Jared W Magnani; Reza Wakili; Sebastian Clauss; Jerome I Rotter; Gerhard Steinbeck; Lenore J Launer; Robert W Davies; Matthew Borkovich; Tamara B Harris; Honghuang Lin; Uwe Völker; Henry Völzke; David J Milan; Albert Hofman; Eric Boerwinkle; Lin Y Chen; Elsayed Z Soliman; Benjamin F Voight; Guo Li; Aravinda Chakravarti; Michiaki Kubo; Usha B Tedrow; Lynda M Rose; Paul M Ridker; David Conen; Tatsuhiko Tsunoda; Tetsushi Furukawa; Nona Sotoodehnia; Siyan Xu; Naoyuki Kamatani; Daniel Levy; Yusuke Nakamura; Babar Parvez; Saagar Mahida; Karen L Furie; Jonathan Rosand; Raafia Muhammad; Bruce M Psaty; Thomas Meitinger; Siegfried Perz; H-Erich Wichmann; Jacqueline C M Witteman; W H Linda Kao; Sekar Kathiresan; Dan M Roden; Andre G Uitterlinden; Fernando Rivadeneira; Barbara McKnight; Marketa Sjögren; Anne B Newman; Yongmei Liu; Michael H Gollob; Olle Melander; Toshihiro Tanaka; Bruno H Ch Stricker; Stephan B Felix; Alvaro Alonso; Dawood Darbar; John Barnard; Daniel I Chasman; Susan R Heckbert; Emelia J Benjamin; Vilmundur Gudnason; Stefan Kääb
Journal:  Nat Genet       Date:  2012-04-29       Impact factor: 38.330

8.  Spatiotemporal characterization of atrial activation in persistent human atrial fibrillation: multisite electrogram analysis and surface electrocardiographic correlations--a pilot study.

Authors:  Samer R Dibs; Jason Ng; Rishi Arora; Rod S Passman; Alan H Kadish; Jeffrey J Goldberger
Journal:  Heart Rhythm       Date:  2008-01-29       Impact factor: 6.343

9.  Inducible and myocyte-specific inhibition of PKCalpha enhances cardiac contractility and protects against infarction-induced heart failure.

Authors:  Michael Hambleton; Allen York; Michelle A Sargent; Robert A Kaiser; John N Lorenz; Jeffrey Robbins; Jeffery D Molkentin
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-10-05       Impact factor: 4.733

10.  Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome.

Authors:  Yana Dautova; Yanmin Zhang; Ian Sabir; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2009-01-28       Impact factor: 3.657

View more
  31 in total

Review 1.  Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy: A Translational Perspective.

Authors:  Stanley Nattel; Jordi Heijman; Liping Zhou; Dobromir Dobrev
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Genotype influence in responses to therapy for atrial fibrillation.

Authors:  Henry Huang; Dawood Darbar
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-07-15

Review 3.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

Review 4.  Dilated Cardiomyopathy: Genetic Determinants and Mechanisms.

Authors:  Elizabeth M McNally; Luisa Mestroni
Journal:  Circ Res       Date:  2017-09-15       Impact factor: 17.367

5.  Heterogeneity of the action potential duration is required for sustained atrial fibrillation.

Authors:  Uma Mahesh R Avula; Jeffrey Abrams; Alexander Katchman; Sergey Zakharov; Sergey Mironov; Joseph Bayne; Daniel Roybal; Anirudh Gorti; Lin Yang; Vivek Iyer; Marc Waase; Deepak Saluja; Edward J Ciaccio; Hasan Garan; Andrew R Marks; Steven O Marx; Elaine Y Wan
Journal:  JCI Insight       Date:  2019-04-25

6.  Genetic ablation or pharmacological inhibition of Kv1.1 potassium channel subunits impairs atrial repolarization in mice.

Authors:  Man Si; Krystle Trosclair; Kathryn A Hamilton; Edward Glasscock
Journal:  Am J Physiol Cell Physiol       Date:  2018-11-14       Impact factor: 4.249

Review 7.  Calcium signalling silencing in atrial fibrillation.

Authors:  Maura Greiser
Journal:  J Physiol       Date:  2017-05-14       Impact factor: 5.182

Review 8.  Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

Authors:  Antoine Bondue; Eloisa Arbustini; Anna Bianco; Michele Ciccarelli; Dana Dawson; Matteo De Rosa; Nazha Hamdani; Denise Hilfiker-Kleiner; Benjamin Meder; Adelino F Leite-Moreira; Thomas Thum; Carlo G Tocchetti; Gilda Varricchi; Jolanda Van der Velden; Roddy Walsh; Stephane Heymans
Journal:  Cardiovasc Res       Date:  2018-08-01       Impact factor: 10.787

9.  Aberrant sialylation causes dilated cardiomyopathy and stress-induced heart failure.

Authors:  Wei Deng; Andrew R Ednie; Jianyong Qi; Eric S Bennett
Journal:  Basic Res Cardiol       Date:  2016-08-09       Impact factor: 17.165

10.  SCN5A: the greatest HITS collection.

Authors:  David S Park; Glenn I Fishman
Journal:  J Clin Invest       Date:  2018-02-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.